Matches in Wikidata for { <http://www.wikidata.org/entity/Q84889057> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q84889057 description "article scientifique publié en 2011" @default.
- Q84889057 description "artículu científicu espublizáu n'avientu de 2011" @default.
- Q84889057 description "scientific article published on 01 December 2011" @default.
- Q84889057 description "wetenschappelijk artikel" @default.
- Q84889057 description "наукова стаття, опублікована в грудні 2011" @default.
- Q84889057 name "Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma" @default.
- Q84889057 name "Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma" @default.
- Q84889057 type Item @default.
- Q84889057 label "Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma" @default.
- Q84889057 label "Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma" @default.
- Q84889057 prefLabel "Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma" @default.
- Q84889057 prefLabel "Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma" @default.
- Q84889057 P1433 Q84889057-D35B5323-DB3C-4256-B24D-A5BF3F4448C8 @default.
- Q84889057 P1476 Q84889057-3E4447C7-A555-499B-8F84-E2EF0D75BD6A @default.
- Q84889057 P2093 Q84889057-03A0B67E-80B8-486B-BEE9-3C19ACA31F03 @default.
- Q84889057 P2093 Q84889057-4C69C535-54E2-43B9-9954-8D13C08F6FB5 @default.
- Q84889057 P2093 Q84889057-5517BAE1-1652-4F96-A90C-CE89D069B331 @default.
- Q84889057 P2093 Q84889057-733FEED7-E6FE-48FC-8B99-3789317CB60B @default.
- Q84889057 P2093 Q84889057-79E46752-EA21-46E9-9BE1-693D962910D1 @default.
- Q84889057 P2093 Q84889057-9B49CFC9-4163-4D64-867B-61176B479731 @default.
- Q84889057 P2093 Q84889057-D5059E53-0C1B-4700-A7FF-1AD938F0BA4A @default.
- Q84889057 P2093 Q84889057-F47E84F9-90B9-4FF4-89B2-25068A7B6507 @default.
- Q84889057 P304 Q84889057-F13ED5D2-1D9A-4909-8D41-91C0BC5ACA7A @default.
- Q84889057 P31 Q84889057-C8974E9F-8860-4E3E-88EE-77A64B1624E7 @default.
- Q84889057 P356 Q84889057-9346AAA1-9558-4DD9-A26B-888BADEF2678 @default.
- Q84889057 P433 Q84889057-A96E8B6E-50DA-4082-BB1D-71641973D126 @default.
- Q84889057 P478 Q84889057-5238E338-E747-420F-8A92-26D00E70A426 @default.
- Q84889057 P577 Q84889057-2D9FEBE0-B4F1-4DD8-9D7D-2B0129FD05E2 @default.
- Q84889057 P698 Q84889057-A7A960BF-D77A-4BD7-81DE-BAF90526D6A2 @default.
- Q84889057 P921 Q84889057-488E66F7-816B-447F-BC5E-5BD04F4B1A41 @default.
- Q84889057 P921 Q84889057-8F94DE36-8095-43CA-950C-F0073FC96BA1 @default.
- Q84889057 P356 JTO.0B013E31822E71C0 @default.
- Q84889057 P698 21892103 @default.
- Q84889057 P1433 Q2448056 @default.
- Q84889057 P1476 "Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma" @default.
- Q84889057 P2093 "Hiroshi Yamamoto" @default.
- Q84889057 P2093 "Kazuhisa Urushihata" @default.
- Q84889057 P2093 "Keishi Kubo" @default.
- Q84889057 P2093 "Masayuki Hanaoka" @default.
- Q84889057 P2093 "Michiko Ito" @default.
- Q84889057 P2093 "Shintaro Kanda" @default.
- Q84889057 P2093 "Tomonobu Koizumi" @default.
- Q84889057 P2093 "Toshihiko Agatsuma" @default.
- Q84889057 P304 "2130-2134" @default.
- Q84889057 P31 Q13442814 @default.
- Q84889057 P356 "10.1097/JTO.0B013E31822E71C0" @default.
- Q84889057 P433 "12" @default.
- Q84889057 P478 "6" @default.
- Q84889057 P577 "2011-12-01T00:00:00Z" @default.
- Q84889057 P698 "21892103" @default.
- Q84889057 P921 Q18936 @default.
- Q84889057 P921 Q7799620 @default.